Emily M. Leproust Twist Bioscience Corp (TWST) insider trading activity

Emily M. Leproust is Chief Executive Officer of Twist Bioscience Corp. Currently has a direct ownership of 645,306 shares of TWST, which is worth approximately $25.2 Million. The most recent transaction as insider was on Jul 02, 2025, when has been sold 476 shares (Common Stock) at a price of $36.19 per share, resulting in proceeds of $17,226. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 645K

2.3% 3M change

27.85% 12M change

Total Value Held $25.2 Million

Emily M. Leproust Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 02 2025	SELL Open market or private sale	$17,226 $36.19 p/Share	476 Reduced 0.07%	645,306 Common Stock
Jun 20 2025	SELL Open market or private sale	$60,005 $35.76 p/Share	1,678 Reduced 0.26%	645,782 Common Stock
Jun 06 2025	SELL Open market or private sale	$68,897 $31.75 p/Share	2,170 Reduced 0.33%	647,460 Common Stock
May 21 2025	SELL Open market or private sale	$83,359 $29.75 p/Share	2,802 Reduced 0.43%	649,630 Common Stock
May 08 2025	SELL Bona fide gift	-	3,000 Reduced 0.46%	652,432 Common Stock
May 05 2025	SELL Open market or private sale	$189,831 $37.65 p/Share	5,042 Reduced 0.76%	655,432 Common Stock
Apr 02 2025	SELL Open market or private sale	$19,055 $38.73 p/Share	492 Reduced 0.07%	660,474 Common Stock
Mar 20 2025	SELL Open market or private sale	$71,939 $41.68 p/Share	1,726 Reduced 0.26%	660,966 Common Stock
Mar 06 2025	SELL Open market or private sale	$98,265 $40.91 p/Share	2,402 Reduced 0.36%	662,692 Common Stock
Feb 21 2025	SELL Open market or private sale	$123,262 $44.18 p/Share	2,790 Reduced 0.42%	665,094 Common Stock
Feb 03 2025	SELL Open market or private sale	$256,620 $49.35 p/Share	5,200 Reduced 0.77%	667,318 Common Stock
Jan 03 2025	SELL Open market or private sale	$24,892 $45.59 p/Share	546 Reduced 0.08%	672,518 Common Stock
Dec 20 2024	SELL Open market or private sale	$74,264 $44.9 p/Share	1,654 Reduced 0.25%	673,064 Common Stock
Dec 06 2024	SELL Open market or private sale	$116,783 $52.7 p/Share	2,216 Reduced 0.33%	674,718 Common Stock
Dec 04 2024	BUY Grant, award, or other acquisition	-	95,350 Added 12.35%	676,934 Common Stock
Nov 11 2024	SELL Open market or private sale	$382,464 $48.0 p/Share	7,968 Reduced 1.35%	581,584 Common Stock
Nov 06 2024	SELL Open market or private sale	$639,296 $44.6 p/Share	14,334 Reduced 2.37%	589,552 Common Stock
Nov 04 2024	SELL Open market or private sale	$201,191 $41.56 p/Share	4,841 Reduced 0.8%	603,886 Common Stock
Nov 04 2024	BUY Grant, award, or other acquisition	-	126,809 Added 17.24%	608,727 Common Stock
Oct 02 2024	SELL Open market or private sale	$587,872 $43.21 p/Share	13,605 Reduced 2.75%	481,918 Common Stock
Sep 20 2024	SELL Open market or private sale	$81,206 $46.94 p/Share	1,730 Reduced 0.35%	495,523 Common Stock
Sep 06 2024	SELL Open market or private sale	$91,634 $39.16 p/Share	2,340 Reduced 0.47%	497,253 Common Stock
Aug 05 2024	SELL Open market or private sale	$205,200 $39.93 p/Share	5,139 Reduced 1.02%	499,593 Common Stock
Jul 02 2024	SELL Open market or private sale	$53,472 $48.0 p/Share	1,114 Reduced 0.22%	504,732 Common Stock
Jun 20 2024	SELL Open market or private sale	$85,578 $49.41 p/Share	1,732 Reduced 0.34%	505,846 Common Stock

Also insider at

SMFR

Sema4 Holdings Corp. Healthcare

EML

Emily M. Leproust

Chief Executive Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TWST shares.

Notify only if

Value

Insider Trading

Get notified when an Twist Bioscience Corp insider buys or sells TWST shares.

Notify only if

Operation

Value

Type

News

Receive news related to Twist Bioscience Corp

Track Activities on TWST

Account